AAA June 2020 – Page 14

Strategies blur as opportunities arise

Interesting to see Søren Thinggaard Hansen has joined Denmark-based pharmaceutical firm Novo as a senior partner to set up a private equity initiative to complement its existing corporate venturing strategy.